NASDAQ · OBLN
Obalon Therapeutics, Inc.
Healthcare · Medical - Devices
$3.05
Down-$0.19 (-5.86%)
Updated Aug 21, 2026, 9:23 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 5.47M
- P/E ratio
- -0.22
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 26.47M
- Avg. volume
- 1.51M
Price performance
OBLN price history
1M range · 0 trading sessions · Daily adjusted prices
OBLN does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest OBLN news
The latest Smart Investors Daily articles mentioning OBLN.
Stock researchCompany · Overview
OBLN research
Overview
Company profile and research snapshot.
Company profile
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 8, 2019 | Canaccord Genuity | Hold | — |
| Feb 26, 2019 | Roth Capital | Neutral | — |
| Feb 25, 2019 | Stifel Nicolaus | Buy | — |
| Sep 11, 2018 | Stifel Nicolaus | Hold | — |
| Sep 6, 2018 | Roth Capital | Buy | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
